Crowdonomics
WatchlistPortfolio
All companies
Naboso logo

Naboso

Operating

Naboso Technology, Inc.

Healthcare · Chandler, AZ · Founded 2016

Visit website

Sensory products to optimise movement

Post-money valuation ⓘ
$10.5M
As of Aug 2021 · from Reg CF Offering (2021) · pre-money + amount raised, not a traded price
Total raised
$653,292
Crowd $553K · Private $100K · 2 rounds since 2017
Latest share price
$0.81
Reg CF · Common Stock · Feb 2021 offering price

Financials

FY2019–FY2025 · from SEC filings · hover any figure for its source
$461K
−$10K
2019
$774K
−$45K
2020
$1.5M
−$468K
2021
$2.8M
−$180K
2022
$3.7M
−$725K
2023
$4.9M
$115K
2024
$6.2M
$424K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed*
FY2020 reviewed
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$461,172
$773,882
$1,494,749
$2,772,932
$3,734,986
$4,884,978
$6,249,830
Cost of goods sold
$125,562
$241,485
$529,978
$870,612
$1,299,320
$1,207,588
$1,947,870
Gross margin
73%
69%
65%
69%
65%
75%
69%
Net income
-$9,949
-$44,920
-$467,762
-$180,346
-$724,790
$114,791
$424,057
Taxes paid
$0
$1,000
$0
$0
$0
$12,049
$14,000
Balance sheet
Cash
$33,799
$62,014
$343,684
$440,647
$333,153
$1,299,700
$935,667
Accounts receivable
$8,955
$10,178
$26,288
$91,335
$0
$50,972
$60,147
Total assets
$185,870
$584,336
$899,667
$1,841,865
$1,725,106
$2,579,855
$28,164,446
Short-term debt
$46,251
$333,729
$286,548
$338,512
$600,628
$476,385
$70,742
Long-term debt
$51,008
$200,916
$247,547
$203,901
$0
$205,000
$209,616
Total liabilities
$97,259
$534,645
$534,095
$542,413
$600,628
$681,385
$280,358
Other
Headcount
5
5
—
5
5
4
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$9.9M
pre-money
Reg CF · Common · Feb 2021

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

$0.81$0.405$0.50
Jan 2017Feb 2021
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Fundraising history

Reg CF · Common Stock · Feb 2021Closedvia StartEngine
Raised $553.3K / $1.1MInvestors 726Post-money $10.5M

Team

1 person
Emily Splichal
CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 5 of 6 annual reports (FY2020–FY2025)

Missing: 2021

726 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 9 filings on EDGAR
  • Form C-ARApr 30, 20260001846931-26-000005
    EDGAR
  • Form C-ARApr 22, 20260001846931-26-000003
    EDGAR
  • Form C-ARApr 29, 20240001665160-24-000587
    EDGAR
  • Form C-ARMay 26, 20230001665160-23-001309
    EDGAR
  • Form C-UOct 27, 20210001665160-21-001896
    EDGAR
  • Form C-UAug 18, 20210001665160-21-001484
    EDGAR
  • Form C-AR/AJun 21, 20210001665160-21-001122
    EDGAR
  • Form C-ARApr 29, 20210001665160-21-000711
    EDGAR
Source: ManualCIK 0001846931DEShare price $0.81

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.